234 related articles for article (PubMed ID: 32377721)
21. miR-26b Targets CEP135 Gene to Regulate Nasopharyngeal Carcinoma Proliferation and Migration by NF-κB Pathway.
Yang G; Zhou J; Guo Z; Fan L; Chen B; Zhang D; Wen H
Mol Biotechnol; 2023 Nov; 65(11):1857-1868. PubMed ID: 36820950
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
23. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ
Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904
[TBL] [Abstract][Full Text] [Related]
24. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
25. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
[No Abstract] [Full Text] [Related]
26. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma.
Fan DC; Zhao YR; Qi H; Hou JX; Zhang TH
Auris Nasus Larynx; 2020 Aug; 47(4):632-642. PubMed ID: 31932074
[TBL] [Abstract][Full Text] [Related]
27. FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.
Dong H; Huang C; Huang J
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278444
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of miR-1181 indicates a dismal prognosis for nasopharyngeal carcinoma and promoted cell proliferation and metastasis by modulating Wnt/β-catenin signaling.
Hua X; Fan KC
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1077-1086. PubMed ID: 30779075
[TBL] [Abstract][Full Text] [Related]
29. miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1.
Jia-Yuan X; Wei S; Fang-Fang L; Zhi-Jian D; Long-He C; Sen L
Biomed Res Int; 2020; 2020():9704245. PubMed ID: 32280708
[TBL] [Abstract][Full Text] [Related]
30. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract][Full Text] [Related]
32. MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
Wang LQ; Deng AC; Zhao L; Li Q; Wang M; Zhang Y
J Biol Regul Homeost Agents; 2019; 33(2):321-330. PubMed ID: 30972994
[TBL] [Abstract][Full Text] [Related]
33. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
Pan Y; Zhou F; Zhang R; Claret FX
PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
[TBL] [Abstract][Full Text] [Related]
34. miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.
Li Y; Yan L; Zhang W; Wang H; Chen W; Hu N; Ou H
Int J Clin Exp Pathol; 2014; 7(6):3478-87. PubMed ID: 25031780
[TBL] [Abstract][Full Text] [Related]
35. Curcumin Increases Radiosensitivity of Radioresistant Nasopharyngeal Cancer.
Wang G; Zhu J; Wang Z; Xu Z; Shi Y; Luo L
Discov Med; 2023 Jun; 35(176):418-428. PubMed ID: 37272108
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of ribophorin II is required for viability of nasopharyngeal cancer cells by regulating JAK1/STAT3 activation.
Wang B; Liu W; Jiang X; Li J; Hu X; Li L; Gu Q
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):471-477. PubMed ID: 34184962
[TBL] [Abstract][Full Text] [Related]
37. Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells.
Liu X; Yang L; Wang H; Xu G; Zhu S; Li M; Hu X; Zhu J; Zhu C; Xu J; Han S; Yu Z
Mol Med Rep; 2015 Apr; 11(4):2504-12. PubMed ID: 25483911
[TBL] [Abstract][Full Text] [Related]
38. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
Ke Z; Xie F; Zheng C; Chen D
J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
[TBL] [Abstract][Full Text] [Related]
39. miR-663 promotes NPC cell proliferation by directly targeting CDKN2A.
Liang S; Zhang N; Deng Y; Chen L; Zhang Y; Zheng Z; Luo W; Lv Z; Li S; Xu T
Mol Med Rep; 2017 Oct; 16(4):4863-4870. PubMed ID: 28765905
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-424-5p inhibits the proliferation, migration, and invasion of nasopharyngeal carcinoma cells by decreasing AKT3 expression.
Zhao C; Zhao F; Chen H; Liu Y; Su J
Braz J Med Biol Res; 2020; 53(7):e9029. PubMed ID: 32520206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
